These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 16936439)
1. Effects of MCI-186 (edaravone), a novel free radical scavenger, upon experimental atherosclerosis in apolipoprotein E-deficient mice. Okabe TA; Kishimoto C; Shimada K; Murayama T; Yokode M; Kita T Circ J; 2006 Sep; 70(9):1216-9. PubMed ID: 16936439 [TBL] [Abstract][Full Text] [Related]
2. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis. Xi H; Akishita M; Nagai K; Yu W; Hasegawa H; Eto M; Kozaki K; Toba K Atherosclerosis; 2007 Apr; 191(2):281-9. PubMed ID: 16806227 [TBL] [Abstract][Full Text] [Related]
3. Effects of late administration of immunoglobulin on experimental atherosclerosis in apolipoprotein E-deficient mice. Okabe TA; Kishimoto C; Shimada K; Murayama T; Yokode M; Kita T Circ J; 2005 Dec; 69(12):1543-6. PubMed ID: 16308506 [TBL] [Abstract][Full Text] [Related]
4. MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats. Nimata M; Okabe TA; Hattori M; Yuan Z; Shioji K; Kishimoto C Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2514-8. PubMed ID: 16100244 [TBL] [Abstract][Full Text] [Related]
5. Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats. Morimoto K; Hasegawa T; Tanaka A; Wulan B; Yu J; Morimoto N; Okita Y; Okada K J Vasc Surg; 2012 Jun; 55(6):1749-58. PubMed ID: 22341578 [TBL] [Abstract][Full Text] [Related]
6. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo. Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991 [TBL] [Abstract][Full Text] [Related]
7. Carvedilol reduces the severity of atherosclerosis in apolipoprotein E-deficient mice via reducing superoxide production. Shimada K; Hirano E; Kimura T; Fujita M; Kishimoto C Exp Biol Med (Maywood); 2012 Sep; 237(9):1039-44. PubMed ID: 22946091 [TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine reduces the severity of atherosclerosis in apolipoprotein E-deficient mice by reducing superoxide production. Shimada K; Murayama T; Yokode M; Kita T; Uzui H; Ueda T; Lee JD; Kishimoto C Circ J; 2009 Jul; 73(7):1337-41. PubMed ID: 19436121 [TBL] [Abstract][Full Text] [Related]
9. Effect of the free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), on hypoxia-ischemia-induced brain injury in neonatal rats. Ikeda T; Xia YX; Kaneko M; Sameshima H; Ikenoue T Neurosci Lett; 2002 Aug; 329(1):33-6. PubMed ID: 12161256 [TBL] [Abstract][Full Text] [Related]
10. [Immunoglobulin stabilizes plaque formation in experimental atherosclerosis]. Shimada K; Kishimoto C; Okabe T; Murayama T; Yokode M; Kita T J Cardiol; 2006 Jun; 47(6):293-7. PubMed ID: 16800372 [TBL] [Abstract][Full Text] [Related]
11. Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production. Shimada K; Murayama T; Yokode M; Kita T; Fujita M; Kishimoto C Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):672-8. PubMed ID: 20399087 [TBL] [Abstract][Full Text] [Related]
12. Short-term administration of a new free radical scavenger, edaravone, is more effective than its long-term administration for the treatment of neonatal hypoxic-ischemic encephalopathy. Noor JI; Ikeda T; Mishima K; Aoo N; Ohta S; Egashira N; Iwasaki K; Fujiwara M; Ikenoue T Stroke; 2005 Nov; 36(11):2468-74. PubMed ID: 16210562 [TBL] [Abstract][Full Text] [Related]
13. Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse. Ikeda K; Iwasaki Y PLoS One; 2015; 10(10):e0140316. PubMed ID: 26469273 [TBL] [Abstract][Full Text] [Related]
14. Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects. Okabe TA; Shimada K; Hattori M; Murayama T; Yokode M; Kita T; Kishimoto C Cardiovasc Res; 2007 Jun; 74(3):537-45. PubMed ID: 17374527 [TBL] [Abstract][Full Text] [Related]
15. Systemic administration of a free radical scavenger, edaravone, protects against light-induced photoreceptor degeneration in the mouse retina. Imai S; Inokuchi Y; Nakamura S; Tsuruma K; Shimazawa M; Hara H Eur J Pharmacol; 2010 Sep; 642(1-3):77-85. PubMed ID: 20553915 [TBL] [Abstract][Full Text] [Related]
16. [Research and development of the free radical scavenger edaravone as a neuroprotectant]. Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127 [TBL] [Abstract][Full Text] [Related]
17. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis. Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842 [TBL] [Abstract][Full Text] [Related]
18. Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice. Sugita M; Sugita H; Kaneki M Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1390-5. PubMed ID: 17363690 [TBL] [Abstract][Full Text] [Related]
19. The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia. Banno M; Mizuno T; Kato H; Zhang G; Kawanokuchi J; Wang J; Kuno R; Jin S; Takeuchi H; Suzumura A Neuropharmacology; 2005 Feb; 48(2):283-90. PubMed ID: 15695167 [TBL] [Abstract][Full Text] [Related]
20. Edaravone (MCI-186), a free radical scavenger, attenuates retinal ischemia/reperfusion injury in rats. Song Y; Gong YY; Xie ZG; Li CH; Gu Q; Wu XW Acta Pharmacol Sin; 2008 Jul; 29(7):823-8. PubMed ID: 18565280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]